A Search and their action mode of microbial bioactive compounds that inhibit osteoclastic Bone Resorption.
Project/Area Number |
16580065
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Applied microbiology
|
Research Institution | Chubu University |
Principal Investigator |
WOO Je Tae Chubu University, College of Bioscience and Biotechnology, Professor, 応用生物学部, 教授 (20272693)
|
Co-Investigator(Kenkyū-buntansha) |
NAGAI Kazuo Chubu University, College of Bioscience and Biotechnology, Professor, 応用生物学部, 教授 (00011974)
OHNISHI Motoko Chubu University, College of Bioscience and Biotechnology, Assistant Professor, 応用生物学部, 助教授 (00312653)
|
Project Period (FY) |
2004 – 2005
|
Project Status |
Completed (Fiscal Year 2005)
|
Budget Amount *help |
¥3,200,000 (Direct Cost: ¥3,200,000)
Fiscal Year 2005: ¥1,400,000 (Direct Cost: ¥1,400,000)
Fiscal Year 2004: ¥1,800,000 (Direct Cost: ¥1,800,000)
|
Keywords | destruxins / reveromycin A / compactin / bone resorption / osteoclast / osteoporosis / coptisine / berberine / 代謝産物 / アルカロイド / ベロマイシン / 細胞骨格 / 骨密度 / 微生物代謝産物 / 機能発現 |
Research Abstract |
In the present study, we determined action mode of reveromycin A (RMA), compactin (mevastatin) and destruxins in cell and molecular level on osteoclast differentiation and function, and screened new compounds from herbs that inhibit osteoclast differentiation. The target molecular of RMA is isoleusyl tRNA synthetase and the selective effect of RM-A on activated osteoclasts is due to the acidified microenviroment which is derived by activated osteoclast. RMA also inhibited the increase of bone resorption in ovariectomised mice. These results indicate that RMA could be a good candidate for a new anti-resorptive medicine with high specificity against activated osteoclasts. Mevastatin was shown to inhibit early differentiation of osteoclasts from their progenitor by decreasing geranylgeranyl pyrophosphate in the pathway of cholesterol synthesis. Geranylgeranyl transferase inhibitor inhibited the geranylgeranylation of small G-protein, suggesting that the geranylgeranylation of small G-protein is involved in the inhibitory effect of mevastatin on early differentiation of osteoclasts. Alkaloids, coptisine (from Coptidis Rhizoma) and berberine (Corydalis Tuber) were found to inhibit osteoclast differentiation. These compounds inhibited osteoclast differentiation by blocking the increase of expression of NFAT which is an essential transcription factor for osteoclast differentiation.
|
Report
(3 results)
Research Products
(23 results)
-
[Journal Article] Reveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclasts.2006
Author(s)
Woo JT, Kawatani M, Kato M, Shinki T, Lee KH, Stern PH, Nagai K, Osada H (他4人)Takami M, Lee KH, Stern PH, Nagai K, Osada H
-
Journal Title
Proc Natl Acad Sci U S A. 13. 103
Pages: 4729-4734
Description
「研究成果報告書概要(和文)」より
Related Report
-
[Journal Article] Curcumin inhibits the proliferation and mineralization of cultured osteoblasts.2006
Author(s)
Notoya M, Nishimura H, Woo JT, Nagai K, Ishihara Y, Hagiwara H, N.Udagawa, In-Sun Lee, Motoko Ohnishi, Hiromi Hagiwara, Kazuo Nagai
-
Journal Title
Eur J Pharmacol. 534
Pages: 55-62
Description
「研究成果報告書概要(和文)」より
Related Report
-
[Journal Article] Reveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclasts.2006
Author(s)
Woo JT, Kawatani M, Kato M, Shinki T, Yonezawa T, Kanoh N, Nakagawa H, Takami M, Lee KH, Stern PH, Nagai K, Osada H.
-
Journal Title
Proc Natl Acad Sci USA. 103(12)
Pages: 4729-4734
Description
「研究成果報告書概要(欧文)」より
Related Report
-
-
-
-
-
-
-
-
-
-
-
-
[Journal Article] Quercetin suppresses bone resorption by inhibiting the differentiation and activation of osteoclasts.2004
Author(s)
Woo, J.-T., Nakagawa, H., Notoya, M., Yonezawa, T., Udagawa, N., Lee, L.-S., Ohnishi, M., Hagiwara, H., Nagai, K.
-
Journal Title
Biol. Pharm. Bull 27
Pages: 504-509
NAID
Description
「研究成果報告書概要(和文)」より
Related Report
-
-
-
-
-
-
-
-
[Journal Article] Furosin, an ellagitannin, suppresses RANKL-induced osteoclast differentiation and function through inhibition of MAP kinase activation and actin ring formation2004
Author(s)
Park EK, Kim MS, Lee SH, Kim KH, Park JY, Kim TH, Lee IS, Woo JT, Jung JC
-
Journal Title
Biochem Biophys Res Commun. 325
Pages: 1472-1480
Related Report